Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
June 20, 2023
Reduced risk of secondary primary extra pulmonary cancer in advanced/metastatic lung cancer patients treated with immune checkpoint inhibitors
P E Heudel, A de Montfort, D Debieuvre, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
October 21, 2021
Evaluation of two modalities of perioperative treatment in the management of extremity and truncal soft tissue sarcomas: neoadjuvant concurrent chemoradiotherapy and sequential treatment
J Attal, B Cabarrou, T Valentin, et al.
The Journal of Nutrition, Health & Aging
|
October 7, 2016
Body Composition and Anti-Neoplastic Treatment in Adult and Older Subjects - A Systematic Review
S Gérard, D Bréchemier, A Lefort, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 30, 2016
Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO)
T Valentin, A Le Cesne, I Ray-Coquard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 25, 2015
Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort
J Mazières, F Barlesi, T Filleron, et al.
ESMO Open
|
May 4, 2024
Incidence and outcome of brain and/or leptomeningeal metastases in HER2-low metastatic breast cancer in the French ESME cohort
N Epaillard, A Lusque, W Jacot, et al.
ESMO Open
|
June 4, 2024
Clinical characteristic and survival outcomes of patients with advanced NSCLC according to KRAS mutational status in the French real-life ESME cohort
Q D Thomas, X Quantin, P Lemercier, et al.
Annals of Surgical Oncology
|
November 22, 2017
Prospective Assessment of First-Year Quality of Life After Pelvic Exenteration for Gynecologic Malignancy: A French Multicentric Study
A Martinez, T Filleron, P Rouanet, et al.
ESMO Open
|
April 17, 2021
Combining immunotherapy with an epidrug in squamous cell carcinomas of different locations: rationale and design of the PEVO basket trial
E de Guillebon, M Jimenez, L Mazzarella, et al.
ESMO Open
|
December 30, 2025
HPV circulating tumor DNA to monitor response to pembrolizumab and vorinostat combination in patients with advanced HPV-related squamous-cell carcinomas
D M Filippini, B Cabarrou, C Dupain, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Lung Cancer (Amsterdam, Netherlands)
|
June 20, 2023
Reduced risk of secondary primary extra pulmonary cancer in advanced/metastatic lung cancer patients treated with immune checkpoint inhibitors
P E Heudel, A de Montfort, D Debieuvre, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
October 21, 2021
Evaluation of two modalities of perioperative treatment in the management of extremity and truncal soft tissue sarcomas: neoadjuvant concurrent chemoradiotherapy and sequential treatment
J Attal, B Cabarrou, T Valentin, et al.
The Journal of Nutrition, Health & Aging
|
October 7, 2016
Body Composition and Anti-Neoplastic Treatment in Adult and Older Subjects - A Systematic Review
S Gérard, D Bréchemier, A Lefort, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 30, 2016
Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO)
T Valentin, A Le Cesne, I Ray-Coquard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 25, 2015
Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort
J Mazières, F Barlesi, T Filleron, et al.
ESMO Open
|
May 4, 2024
Incidence and outcome of brain and/or leptomeningeal metastases in HER2-low metastatic breast cancer in the French ESME cohort
N Epaillard, A Lusque, W Jacot, et al.
ESMO Open
|
June 4, 2024
Clinical characteristic and survival outcomes of patients with advanced NSCLC according to KRAS mutational status in the French real-life ESME cohort
Q D Thomas, X Quantin, P Lemercier, et al.
Annals of Surgical Oncology
|
November 22, 2017
Prospective Assessment of First-Year Quality of Life After Pelvic Exenteration for Gynecologic Malignancy: A French Multicentric Study
A Martinez, T Filleron, P Rouanet, et al.
ESMO Open
|
April 17, 2021
Combining immunotherapy with an epidrug in squamous cell carcinomas of different locations: rationale and design of the PEVO basket trial
E de Guillebon, M Jimenez, L Mazzarella, et al.
ESMO Open
|
December 30, 2025
HPV circulating tumor DNA to monitor response to pembrolizumab and vorinostat combination in patients with advanced HPV-related squamous-cell carcinomas
D M Filippini, B Cabarrou, C Dupain, et al.
Page
of 5